Mobile

Phase III study of efficacy and safety in Polycythemia Vera subjects who are restistant or intolerant of hydroxyurea

Update Il y a 4 ans
Reference: EUCTR2010-020807-57

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To compare the efficacy of INC424 to Best Available Therapy (BAT) as assessed by both the absence of phlebotomy eligibility and reduction in spleen volume.

Inclusion criteria

  • Polycythemia Vera

Links